Search - tctmd.com

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

December 30, 2016

News Conference News TCT 2016

No Scares From SCAAR: Stent Thrombosis Rates in Newest DES Are Similar—and Low

November 07, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Features

The Bioresorbable Stent Story So Far: What Promise? What Price?

Michael O'Riordan

August 17, 2016

News Daily News

Now You See It: FDA Approves Absorb Bioresorbable Scaffold

Michael O'Riordan

July 05, 2016

News Conference News TCT 2015

Novel Devices Present New Treatment Options for STEMI

October 11, 2015

News Conference News ESC 2015

EXAMINATION: STEMI Patients Fare Better at 5 Years With EES vs BMS

Caitlin E. Cox

September 02, 2015

News Daily News

COMPARE:5 年时 EES 的疗效仍优于 PES

July 30, 2015

News Daily News

COMPARE: Los EES siguen siendo Superiores a los SLP a los 5 Años

July 30, 2015

News Daily News

COMPARE: EES Maintains Advantage Over PES at 5 Years

July 30, 2015

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

July 29, 2015

News Daily News

BASKET-PROVE 亚组研究：DES 对有大动脉的老年患者的治疗效果优于 BMS

July 29, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

July 29, 2015

News Daily News

研究证实采用较新DES时支架内血栓形成和心肌梗死风险降低

November 02, 2014

News Daily News

Un Estudio Confirma Menor Riesgo de Trombosis del Stent,IM con los Nuevos SLF

November 02, 2014

News Daily News

Study Confirms Lower Stent Thrombosis, MI Risks With Newer DES

November 02, 2014

Presentation TCT 2014

Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study_

Presenter: Krishnankutty Sudhir

September 16, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI